Pre-Screening Prodromal AD Trial Populations over the Telephone Using a Speech Biomarker for Cognition — Preliminary Results from AUTONOMY Phase 2 AD Trial Recruitment

Stephen Ruhmel, Johannes Tröger, Nicklas Linz, Janna Hermann, Mary Quiceno, and Kai Langel

Poster presented at the 15th Conference Clinical Trials Alzheimer’s Disease, 2022